| 1 | AMPD3
|
| Characterization of the human AMPD3 gene reveals that 5' exon useage is subjectto transcriptional control by three tandem promoters and alternative splicing.
|
| Mahnke-Zizelman DK, Eddy R, Shows TB, Sabina RL.
|
| Biochim Biophys Acta 1306(1):75-92. 1996
|
| 2 | AMPD3
|
| Molecular basis for human erythrocyte AMP deaminase deficiency : screening for the major point mutation and identification of other mutations.
|
| Yamada Y, et al.
|
| Hum Mol Genet 3 : 2243-2245. 1994
|
| 3 | AMPD3
|
| A point mutation responsible for human erythrocyte AMP deaminase deficiency.
|
| Yamada Y, et al.
|
| Hum Mol Genet 3 : 331-334. 1994
|
| 4 | AMPD2, AMPD3
|
| Distribution of the AMP deaminase multigene family within the human genome : assignment of the AMPD2 to chromosome 1p21-p34 and AMPD3 to chromosome 11p13-pter.
|
| Eddy RL, et al.
|
| HGMW 93 1993
|
| 5 | AMPD3
|
| Cloning of human AMP deaminase isoform E cDNAs. Evidence for a third AMPD geneexhibiting alternatively spliced 5'-exons.
|
| Mahnke-Zizelman DK, Sabina RL.
|
| J Biol Chem 267(29):20866-77. 1992
|
| 6 | AMPD3
|
| Cloning and nucleotide sequence of the cDNA encoding human erythrocyte-specificAMP deaminase.
|
| Yamada Y, Goto H, Ogasawara N.
|
| Biochim Biophys Acta 1171(1):125-8. 1992
|